We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 1 of 1
Most popular |Most recent


Follow-on biologics and patent reform: will they discourage venture capital investment in the biotechnology industry?

USA - July 31 2009 According to a study by PricewaterhouseCoopers and the National Venture Capital Association, venture capital (VC) investing hit a five-year high in 2006, with $25.5 billion invested....

Donald R. Ware.